DUBLIN, Calif., Sept. 18 SuperGen, Inc.(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapiddevelopment and commercialization of therapies for solid tumors andhematological malignancies, today announced that James S. Manuso, Ph.D.,President and Chief Executive Officer, is scheduled to present at the UBSGlobal Life Sciences Conference on Thursday, September 25, 2008, at The GrandHyatt New York.
SuperGen's presentation at the UBS Global Life Sciences Conference isscheduled to begin at 12:30 p.m. EDT (9:30 a.m. PDT). A live webcast of thepresentation will be available on the investor relations section of theCompany's Web site at http://www.supergen.com. A webcast replay of thepresentation will be available shortly following the live event.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery and development of novel cancer therapies. SuperGenis developing a number of therapeutic anticancer products focused on kinaseand cell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit http://www.supergen.com.Contacts: SuperGen, Inc. Dorland Global Public Relations Timothy L. Enns Michael Beckerich (Media) SVP, Corporate Communications Tel: (212) 677-7632 & Business Development [email protected]
Tel: (925) 560-0100 Email: [email protected]
Mary M. Vegh Manager, Investor Relations Tel: (925) 560-2845 E-mail: [email protected]
SOURCE SuperGen, Inc.